Lecture 4: Dry Powder Inhaler Flashcards
Inhalation dosage forms
-local and systemic
Local application of inhalation dosage forms
-high local concentration
-fast action
-lower systemic side effects
-asthma, COPD, lung infection
systemic application of inhalation dosage form
-rapid absorption
-fewer drug-metabolizing enzymes
fluticasone
-less than 1% bioavailability in oral form bc of first-pass effect
-plasma binding is more than 99% (less than 1% of drug available)
-systemic adminstation = side effects (hypercorticism)
Inhaled fluticasone
-absolute bioavailability (~10%)
-safe for children under 1
Aystemic application of inhaled medicines
-300-500 million alveoli in lungs
-huge surface area of lungs
Alveoli
-surrounded by lung capillaries
-thin walls for gas exchange (good for absorption)
-nonciliated
Respiratory tract regions
-extrathoracic (head and neck)
-upper bronchial region (trachea and bronchi)
-lower bronchial region (braonchioles)
-alveolar region
Bronchi
-large ciliated airways
bronchioles
-small ciliated airways
Particle deposition mechanisms
-diffusional transport
-inertial transport
-gravitational transport
diffusional transport
-ultrafine particles
-alveoli
-tend to be exhaled without depositing
-alveolar region
Gravitational transport
-sedimentation
-slightly bigger particles than diffusional
-increase with diameter and density
-bronchial and alveolar region
Inertial transport
-impaction
-driven by momentum
-increase with particle velocity, diameter, density
-extrathoracic region
Sedimentation increases with:
-density
-acceleration due to gravity
-diameter
-slip correction factors
Sedimentation decreases with:
-shape factors
-viscosity
sedimentation equation
-terminal settling velocity
Aerodynamic diameter (Dae)
-diameter of particle with unit mass density of 1g/cm3 that would settle at the same velocity as particle of interest
-EQUATION SLIDE 10
=(density)^0.5 x Dgeo